Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.

Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.

Am J Kidney Dis. 2015 Oct;66(4):613-20. doi: 10.1053/j.ajkd.2015.03.025. Epub 2015 May 12.

PMID:
25975963
2.

[Four years of simultaneous pancreas-kidney transplantations in Finland].

Lempinen M, Nordin A, Ortiz F, Koskinen P, Ekstrand A.

Duodecim. 2014;130(20):2079-85. Finnish.

PMID:
25558605
3.

Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis.

Salmela A, Ekstrand A, Joutsi-Korhonen L, Räisänen-Sokolowski A, Lassila R.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i53-9. doi: 10.1093/ndt/gfu379. Epub 2014 Dec 18.

PMID:
25523447
4.

Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.

Rasmussen N, Salmela A, Ekstrand A, de Groot K, Gregorini G, Cohen Tervaert JW, Gross WL, Wiik A, Jayne DR; European Vasculitis Study Group (EUVAS).

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S38-44. Epub 2013 Feb 1.

PMID:
23380137
5.

Miscommunication involving 'standard care'. Response to protocol review scenario: describe in detail.

Ekstrand A, Lukas V.

Lab Anim (NY). 2011 Mar;40(3):67. doi: 10.1038/laban0311-67. No abstract available.

PMID:
21326184
6.

Pharmacokinetics of ropivacaine in patients with chronic renal failure.

Pere PJ, Ekstrand A, Salonen M, Honkanen E, Sjövall J, Henriksson J, Rosenberg PH.

Br J Anaesth. 2011 Apr;106(4):512-21. doi: 10.1093/bja/aer002. Epub 2011 Feb 8.

7.

Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor.

Jönsson M, Ekstrand A, Edekling T, Eberhard J, Grabau D, Borg D, Nilbert M.

BMC Clin Pathol. 2009 Oct 15;9:8. doi: 10.1186/1472-6890-9-8.

8.

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.

Ekstrand AI, Jönsson M, Lindblom A, Borg A, Nilbert M.

Fam Cancer. 2010 Jun;9(2):125-9. doi: 10.1007/s10689-009-9293-1.

PMID:
19731079
9.
10.

Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?

Martikainen TA, Teppo AM, Grönhagen-Riska C, Ekstrand AV.

Perit Dial Int. 2005 Sep-Oct;25(5):453-60.

11.

Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients.

Martikainen T, Teppo AM, Gronhagen-Riska C, Ekstrand A.

Blood Purif. 2005;23(4):303-10. Epub 2005 Jun 23.

PMID:
15980620
12.

Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.

Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, Macnamara E, Ekstrand A, Tranaeus A, Filho JC; EAPOS Group.

Kidney Int. 2005 Apr;67(4):1609-15.

13.

Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.

Watz R, Ekstrand AB, Engelbrektson V, Beermann B.

Eur J Clin Pharmacol. 2005 May;61(3):209-14. Epub 2005 Mar 11.

PMID:
15761755
14.

Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: predictors of outcome of peritonitis?

Martikainen TA, Ekstrand AV, Honkanen EO, Teppo AM, Grönhagen-Riska C.

Blood Purif. 2004;22(4):360-6. Epub 2004 Aug 3.

PMID:
15297786
15.

Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.

Quéva C, Bremner-Danielsen M, Edlund A, Ekstrand AJ, Elg S, Erickson S, Johansson T, Lehmann A, Mattsson JP.

Br J Pharmacol. 2003 Sep;140(2):315-22. Epub 2003 Aug 11.

16.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group.

N Engl J Med. 2003 Jul 3;349(1):36-44.

17.

Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.

Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, Nordlander M, Cao Y.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6033-8. Epub 2003 May 2. Erratum in: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2554.

18.

Cytokines and other soluble factors in dialysate -- indicators of altered peritoneal function?

Martikainen TA, Ekstrand AV, Teppo AM, Honkanen EO, Grönhagen-Riska C.

Scand J Urol Nephrol. 2002;36(6):450-4.

PMID:
12623511
19.

Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain.

Lehmann A, Mattsson JP, Edlund A, Johansson T, Ekstrand AJ.

Neurochem Res. 2003 Feb;28(2):387-93.

PMID:
12608713
20.

Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation.

Naveilhan P, Svensson L, Nyström S, Ekstrand AJ, Ernfors P.

Peptides. 2002 Jun;23(6):1087-91.

PMID:
12126735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk